robin thadathil people page on Anadi Algo News

Thursday, March 19, 2026
DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|
People Landing|5 matching stories

robin thadathil News, Mentions & Market Context

AI-analyzed market coverage and mentions for robin thadathil, including related stories and trading context.

FMCG stocks generally offer stability; however, this news provides no specific catalyst for trading P&G India's listed entities. Focus on broader market sentiment for entry/exit points.|Quick check: PGHL neutral, GILLETTE bearish bias (+0.7% 1d).
et_companies5 days ago

Kathua to become India’s antibiotic powerhouse with Rs 600 crore pharma facility

The Indian pharma sector is actively working to reduce its reliance on imported APIs, especially from China. This investment aligns with the government's 'Make in India' push and Production Linked Incentive (PLI) schemes for pharmaceuticals.

Look for opportunities in API-focused pharma companies, as this development signals continued government support and potential for domestic growth, with a bias towards long positions.|Quick check: AUROPHARMA bullish bias (overbought), DIVISLAB bearish bias (-3.5% 1d).
et_markets7 days ago

Coal India among 4 stocks that hit 52-week highs & rallied up to 15% in a month

The pharma sector is seeing sustained interest, with several articles highlighting 'best stocks' and 'multibaggers' for 2025-2026, suggesting a positive long-term outlook. The power sector is also showing strong short-term momentum, as evidenced by the BSE Power index surge.

For pharma, look for companies with strong product pipelines and favorable regulatory signals for potential long-term growth. For power, consider short-term momentum plays given the recent index surge, but be mindful of potential profit-booking.|Quick check: COALINDIA bullish bias (overbought), AUROPHARMA bullish bias (overbought).

Latest robin thadathil Mentions